RO7223280

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Bacterial InfectionsHealthy Volunteers

Phase 1

A Study To Investigate The Safety, Tolerability And Pharmacokinetics (PK) Of RO7223280 Following Intravenous Administration In Healthy Participants

CompletedNCT04605718

Hoffmann-La RocheHealthy Volunteers

Start: 2020-12-07End: 2023-03-09Updated: 2023-04-18

A Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Participants With Bacterial Infections

CompletedNCT05614895

Hoffmann-La RocheBacterial Infections

Start: 2022-12-03End: 2024-01-13Updated: 2024-01-22